NEEDHAM, MA--(Marketwired - June 01, 2016) - Insight Pharma Reports, a division of Healthtech Publishing, announces a series of leading market research reports focusing on respiratory diseases through our Affiliated Reports Collection.

Titles now available through our network of publishers include:

Idiopathic Pulmonary Fibrosis-Pipeline Insights

Targeted Therapies In Asthma: KOL Insight

Global Asthma Partnering

Global COPD Partnering

Global Idiopathic Pulmonary Fibrosis Partnering

Global Respiratory Partnering 2010-2016: Deal trends, players and financials

Lung Transplantation - Pipeline Review

Respiratory Syncytial Virus (RSV) Infections - Pipeline Review

Lung Adenocarcinoma - Pipeline Review

Acute Respiratory Distress Syndrome

Cystic Fibrosis - Pipeline Review

Global Pneumonia Partnering

Global Respiratory Devices Market

Lung Disease - Pipeline

Cystic Fibrosis Therapeutics in Major Developed Markets to 2019 - CFTR Modulators Initiate Drive towards Personalized Treatment and Market Growth

For more information on these reports visit: InsightPharmaReports.com/Respiratory-Diseases-Reports

About Insight Pharma Reports (www.insightpharmareports.com)
Insight Pharma Reports, a division of Healthtech Publishing, is the premier life sciences information provider offering unparalleled coverage of key issues in drug discovery and development. The reports are used by leading pharmaceutical, biotech, diagnostic, and other life science companies to keep abreast of the latest developments in pharmaceutical R&D and their potential applications and business impacts. The reports are written by experts in consulting and industry, and are supported by hundreds of hours of primary and secondary research. Insight Pharma Reports provide comprehensive coverage of salient issues in a concise, well-organized format.

About Healthtech Publishing (www.healthtechpublishing.com)
Healthtech Publishing, a division of Cambridge Healthtech Institute, provides the life science communities with business critical intelligence through research reports and digital news, helping decision makers to gain competitive advantage and make strategic decisions. Our portfolio consists of Insight Pharma Reports' vast research reports collection and three niche digital subscription products: Bio-IT World, Clinical Informatics News and Diagnostics World.